Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Available × telisotuzumab vedotin × Thoracic × Clear all

Status

Recruiting 2 Terminated 1 Not yet recruiting 1 Available 1 Active not recruiting 1

Sponsor Class

Study Type

Expanded_access 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 1

Interventions

ulixertinib 1 telisotuzumab vedotin 1 epigallocatechin gallate 1 ensartinib 1 ceritinib 1 balstilimab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04830202 2026-02-06

Expanded Access to Telisotuzumab Vedotin

AbbVie

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon ⚡